Morgan Stanley ponders if Eli Lilly could be the first $1 trillion pharma stock on weight loss boom

Eli Lilly's 'diabesity' medications are positioning it to become the first pharmaceutical company to hit $1 trillion in market cap, Morgan Stanley said.



Source link